Centers | ||
|
|
|
Therapeutic Accelerator Program (TAP) | UCSC Chemical Screening Center | Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) |
Test |
We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of... |
The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... |
Partnerships |
Events |
Jobs |
TB Drug Accelerator
View all Cerecor Partners with Johns Hopkins Brain Science Institute to Treat SchizophreniaCerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are currently being developed by researchers at the Johns... View all Sanofi and MIT Form New Partnership to Foster Industry - Academic CollaborationSanofi and MIT's Center for Biomedical Innovation has established a new partnership to foster basic and applied research and develop solutions to address unmet clinical needs. Sanofi will be providing funding to support specific research projects... View all |
No EVENTS for listing |
No Job Posts |
